1. Home
  2. FLGC vs CTXR Comparison

FLGC vs CTXR Comparison

Compare FLGC & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLGC
  • CTXR
  • Stock Information
  • Founded
  • FLGC 2019
  • CTXR 2007
  • Country
  • FLGC United States
  • CTXR United States
  • Employees
  • FLGC N/A
  • CTXR N/A
  • Industry
  • FLGC Biotechnology: Pharmaceutical Preparations
  • CTXR Biotechnology: Pharmaceutical Preparations
  • Sector
  • FLGC Health Care
  • CTXR Health Care
  • Exchange
  • FLGC Nasdaq
  • CTXR Nasdaq
  • Market Cap
  • FLGC 15.9M
  • CTXR 14.6M
  • IPO Year
  • FLGC 2021
  • CTXR N/A
  • Fundamental
  • Price
  • FLGC $0.61
  • CTXR $1.53
  • Analyst Decision
  • FLGC Buy
  • CTXR Strong Buy
  • Analyst Count
  • FLGC 2
  • CTXR 3
  • Target Price
  • FLGC $4.00
  • CTXR $53.00
  • AVG Volume (30 Days)
  • FLGC 106.1K
  • CTXR 6.7M
  • Earning Date
  • FLGC 08-11-2025
  • CTXR 08-11-2025
  • Dividend Yield
  • FLGC N/A
  • CTXR N/A
  • EPS Growth
  • FLGC N/A
  • CTXR N/A
  • EPS
  • FLGC N/A
  • CTXR N/A
  • Revenue
  • FLGC $53,260,000.00
  • CTXR N/A
  • Revenue This Year
  • FLGC N/A
  • CTXR N/A
  • Revenue Next Year
  • FLGC N/A
  • CTXR N/A
  • P/E Ratio
  • FLGC N/A
  • CTXR N/A
  • Revenue Growth
  • FLGC N/A
  • CTXR N/A
  • 52 Week Low
  • FLGC $0.42
  • CTXR $0.65
  • 52 Week High
  • FLGC $2.11
  • CTXR $26.25
  • Technical
  • Relative Strength Index (RSI)
  • FLGC 42.89
  • CTXR 68.44
  • Support Level
  • FLGC $0.62
  • CTXR $0.76
  • Resistance Level
  • FLGC $0.72
  • CTXR $1.45
  • Average True Range (ATR)
  • FLGC 0.06
  • CTXR 0.31
  • MACD
  • FLGC -0.01
  • CTXR 0.06
  • Stochastic Oscillator
  • FLGC 14.79
  • CTXR 47.63

About FLGC Flora Growth Corp.

Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are: the commercial and wholesale segment (FGH and Cosechemos subsidiaries) and the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries). Geographically, the company generates revenue from the United States, Germany, Australia, and the United Kingdom. It generates revenue as a distributor of pharmaceutical goods, and a manufacturer and reseller of a range of cannabis-based and complementary products.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

Share on Social Networks: